Skip to main content
I.Ceram logo

I.Ceram — Investor Relations & Filings

Ticker · ALICR ISIN · FR0011511971 LEI · 969500R28RHD3HDEIL86 PA Manufacturing
Open in API
Filings indexed 157 across all filing types
Latest filing 2016-11-15 AGM Information
Country FR France
Listing PA ALICR

About I.Ceram

https://www.iceram.fr/

I.Ceram specializes in the design, manufacture, and marketing of orthopedic and reconstructive implants. The company's core technology is centered on porous alumina bioceramics, though it also utilizes metals and polymers. A key innovation is the development of active implants, such as its Ceramil line, which can be loaded with antibiotics like gentamicin. This feature enables the localized delivery of medication directly to bone tissue to prevent and treat infections post-surgery. The product portfolio includes implants for various joints and a bioceramic sternal implant designed for reconstructive procedures.

Recent filings

Filing Released Lang Actions
I.CERAM participe au salon ACTIONARIA les 18 et 19 novembre 2016
AGM Information Classification · 1% confidence The document is a short announcement from I.CERAM stating its participation in the ACTIONARIA shareholder meeting/trade show on November 18 and 19, 2016. It details the stand location and the schedule for the CEO's participation in roundtables. This is not a formal regulatory filing (like 10-K, IR, ER), nor is it a presentation (IP) or a formal AGM result (DVA). It is an announcement about the company's presence at an investor event, which aligns best with general investor relations communication, specifically related to meeting shareholders. Since there is no specific category for 'Event Participation Announcement', and it is not a formal report, it falls under general investor communication. Given the context of meeting shareholders and discussing strategy, it is closest to general investor information, but the most fitting category for an announcement about an upcoming event where management will interact with investors, without being a formal AGM or a presentation, is often categorized under general Regulatory Filings (RNS) if a more specific category like 'Investor Relations Event Announcement' is missing. However, since it is an announcement about meeting shareholders, it is a form of investor communication. Given the options, and that it is a brief announcement about an upcoming event rather than a core financial report, RNS (Regulatory Filings/Miscellaneous Announcement) is the safest fallback, although it strongly relates to investor engagement. Since it is an announcement about an event where management will speak to investors, it is not a DEF 14A (Remuneration) or DVA (Voting Results). It is an announcement of management presence at a public forum. I will classify this as a general Regulatory Filing (RNS) as it is a non-standard, informational announcement.
2016-11-15 French
Succès de la gamme CERAMIL® - Participation au congrès de la SOFCOT à Paris
Regulatory Filings Classification · 1% confidence The document is a press release written in French detailing the success of the company I.CERAM at the SOFCOT congress in Paris, highlighting a first-time surgical implantation using their CERAMIL® sternum implant and upcoming commercialization plans. It discusses product innovation, participation in industry events, and provides company background information, including its listing on Alternext Euronext Paris. This content is characteristic of a general corporate announcement or news release, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general announcement about company activities and achievements, and does not fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate news releases that don't fit elsewhere, although it reads more like a general press release. Given the options, RNS is the best fit for a non-standard, general corporate update.
2016-11-08 French
Nouvelle étape stratégique réussie pour I.CERAM : 1ère implantation humaine d’une céramique (Céramil®) chargée en antibiotique
Regulatory Filings Classification · 1% confidence The document announces a successful first human implantation of a specific medical device (Céramil®), details the medical case, discusses the strategic milestone achieved, outlines future steps (CE marking, multicenter study), and provides company background and contact information. This is a press release or news announcement detailing a significant operational and clinical achievement, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). Since it is a general announcement about a company milestone and not specifically about management changes (MANG), director dealings (DIRS), dividends (DIV), or financing (CAP), the most appropriate general category for a significant, non-standard corporate announcement that doesn't fit other specific codes is Regulatory Filings (RNS), which often serves as a catch-all for press releases or significant operational news not covered elsewhere, especially in a European context where RNS is common for regulatory news dissemination.
2016-11-02 French
Implants chargés en antibiotiques : Confirmation des cinétiques de relargage
Regulatory Filings Classification · 1% confidence The document discusses the finalization of the first phase of testing for antibiotic release kinetics from I.CERAM's ceramic implants. It details the scientific rationale, the antibiotics tested (gentamicin and vancomycin), and the positive *in vitro* results regarding immediate and prolonged release. Crucially, the document ends with a forward-looking statement: "Prochaine communication : Résultats semestriels 2016 – 26 octobre 2016 après bourse" (Next communication: 2016 semi-annual results – October 26, 2016 after market close). This structure—providing an update on R&D progress and announcing the date for the next financial report (semi-annual results)—is characteristic of a general corporate update or press release that is not the full financial report itself (like 10-K or IR). Since it is an announcement about scientific progress and not a formal regulatory filing like a Director's Dealing or Major Shareholding, and it is not a transcript or a presentation, it best fits the general category for regulatory/corporate announcements that don't fit elsewhere, which is Regulatory Filings (RNS), or potentially an Investor Presentation (IP) if it were structured as slides, but given the press release format, RNS is the most appropriate fallback for a non-standard corporate update.
2016-10-17 French
Nomination Aure´lie Hardy - Responsable Ressources Humaines
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of Aurélie Hardy as the Head of Human Resources for I.CERAM. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The content focuses entirely on a personnel change and its strategic implications, not on financial results, regulatory compliance, or shareholder votes. Therefore, the appropriate code is MANG.
2016-10-04 French
Participation à l’European Large & Midcap Event 2016
Report Publication Announcement Classification · 1% confidence The document is a short announcement from I.CERAM stating its participation in the 'European Large & Midcap Event' on specific dates. It details who will attend (CFO, Scientific Director) to meet investors and present company news and development prospects. This type of communication, focused on management meeting investors at a specific industry event, is best classified as an Investor Presentation (IP) or a general announcement related to investor relations activities. Since it is not a formal regulatory filing (like 10-K or IR) but an announcement about management engaging with investors at a promotional event, 'Investor Presentation' (IP) is the most fitting category, as these events often involve presenting company materials to potential investors. Given the context of management meeting investors to present 'l'actualité d'I.CERAM ainsi que ses perspectives de développement,' it aligns closely with the purpose of an Investor Presentation, even if it's an announcement *about* attending the event.
2016-09-30 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.